- Q1 2024 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 08, 2024$25.04 (-3.36%)Earnings
- Q4 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptFeb 28, 2024$28.89 (-2.43%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Mirum Pharmaceuticals Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptNov 02, 2023$28.39 (-0.11%)Earnings
- Mirum Pharmaceuticals Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 28, 2023
- Mirum Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Q2 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptAug 03, 2023$24.88 (-0.16%)Earnings
- Mirum Pharmaceuticals Inc To Acquire Travere Therapeutics Inc Call TranscriptJul 17, 2023
- Q1 2023 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 04, 2023$27.85 (-2.59%)Earnings
- Q4 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptMar 08, 2023$23.76 (-0.13%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Q3 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptNov 09, 2022$20.02 (-16.37%)Earnings
- Mirum Pharmaceuticals Inc To Discuss The Topline Data From the MARCH Study Call TranscriptOct 24, 2022
- Q2 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptAug 04, 2022$26.05 (+11.80%)Earnings
- Q1 2022 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 05, 2022$25.03 (+6.15%)Earnings
- Q4 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptMar 09, 2022$22.8 (+7.55%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Q3 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptNov 15, 2021$15.49 (-2.46%)Earnings
- Mirum Pharmaceuticals Inc To Discuss FDA Approves LIVMARLI Call TranscriptSep 29, 2021
- Q2 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptAug 05, 2021$14.54 (-0.62%)Earnings
- Q1 2021 Mirum Pharmaceuticals Inc Earnings Call TranscriptMay 06, 2021$17.7 (-6.50%)Earnings
- Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Mirum Pharmaceuticals Inc Corporate Analyst Meeting TranscriptDec 09, 2020
Q4 2023 Mirum Pharmaceuticals Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen. Thank you for joining today's Mirum Pharmaceuticals reports Q4 year end 2023 financial results and provides business update. My name is Tia, and I will be your moderator for today's call. (Operator instructions)
It is my pleasure to pass the call over to Andrew McKibben, Vice President of Investor Relations and Finance. Please proceed.
Thanks, Tia, and good afternoon, everyone. I'd like to welcome you to Mirum Pharmaceuticals fourth-quarter 2023 conference call. I'm joined today by our CEO, Chris Peetz; President and Chief Operating Officer, Peter Radovich; our Chief Scientific Officer and Head of Research, Pam Vig; our Chief Medical Officer Joanne Quan; and Eric Bjerkholt, our Chief Financial Officer.
Earlier today, Mirum issued a news release announcing the company's results for the fourth-quarter and full-year 2023. Copies of this news release and SEC filings can be found in the Investors section of our website.
Before we begin,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)